Molecular evolution of ubiquitous beta-lactamases towards extended-spectrum enzymes active against newer beta-lactam antibiotics.
about
Sequence analysis of PER-1 extended-spectrum beta-lactamase from Pseudomonas aeruginosa and comparison with class A beta-lactamases.Identification and minisequencing-based discrimination of SHV beta-lactamases in nosocomial infection-associated Klebsiella pneumoniae in Brisbane, AustraliaGenetic analysis of clinical isolates of Streptococcus pneumoniae with high-level resistance to expanded-spectrum cephalosporins.Construction and characterization of an OHIO-1 beta-lactamase bearing Met69Ile and Gly238Ser mutations.Extended-spectrum beta-lactamases in enterobacteriaceae in Buenos Aires, Argentina, public hospitalsEmergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 beta-lactamase conferring resistance to beta-lactamase inhibitors.Epidemiology of plasmid-mediated beta-lactamases in enterobacteria Swedish neonatal wards and relation to antimicrobial therapy.Antibiotic-resistant soil bacteria in transgenic plant fields.Genetic and biochemical analysis of a novel Ambler class A beta-lactamase responsible for cefoxitin resistance in Bacteroides species.Cloning and sequence analysis of the gene for a carbapenem-hydrolyzing class A beta-lactamase, Sme-1, from Serratia marcescens S6Identification of amino acid substitutions that alter the substrate specificity of TEM-1 beta-lactamase.Five independent combinations of mutations can result in low-affinity penicillin-binding protein 2x of Streptococcus pneumoniaeMicrobial systems and directed evolution of protein activities.Catalytic properties of class A beta-lactamases: efficiency and diversity.Mechanism of acyl transfer by the class A serine beta-lactamase of Streptomyces albus G.
P2860
Q33747422-A5E08F81-5CFD-45C1-B9BC-25A76A217BDAQ34113586-658314E5-EAEE-406B-B819-7490A9BEEB36Q35115272-9B09DE08-3B23-48FB-99C6-6C0A0ADB0EB1Q35138077-4742E4EE-9C2A-4F3C-B66D-2FAD7F4C85F1Q35685785-1CB6E8C6-1605-4971-85C0-7B0C0870F31FQ35820623-7CE47DD5-C378-4CF8-BCDB-CD1330007A10Q35835805-5FA3B272-6D93-4C63-AD57-156B5A0C0FD9Q36499090-9B991820-BB42-4533-B423-06A3620AC4D7Q36785845-7FC0B9DD-A71A-46FE-9665-DF9779A0558CQ39867049-80277781-BA79-4C2B-B22E-FA2CA11A3C1FQ39935716-162EBCD5-36A2-4CD8-85D1-6BB3C0C27EC6Q39945759-4EE1C5E3-6B09-406F-BD92-6DE2604F4E50Q40699646-C805F276-113C-42CB-989C-33246E090650Q40863105-FBDD3174-902C-4E58-A9AE-83E5BFE4BDF4Q42096416-5186ED0D-FB41-4B4A-ABA1-AB94C993280D
P2860
Molecular evolution of ubiquitous beta-lactamases towards extended-spectrum enzymes active against newer beta-lactam antibiotics.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1990
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular evolution of ubiquit ...... newer beta-lactam antibiotics.
@en
Molecular evolution of ubiquit ...... newer beta-lactam antibiotics.
@nl
type
label
Molecular evolution of ubiquit ...... newer beta-lactam antibiotics.
@en
Molecular evolution of ubiquit ...... newer beta-lactam antibiotics.
@nl
prefLabel
Molecular evolution of ubiquit ...... newer beta-lactam antibiotics.
@en
Molecular evolution of ubiquit ...... newer beta-lactam antibiotics.
@nl
P2093
P2860
P1476
Molecular evolution of ubiquit ...... newer beta-lactam antibiotics.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2958.1990.TB00537.X
P407
P577
1990-10-01T00:00:00Z